Patents by Inventor Donald Smyth
Donald Smyth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11575535Abstract: Systems and methods for providing contextual interaction with connected devices are described. A mobile device having a display that presents a user interface enabling access to functionalities provided by connected devices. The user interface may be updated as various contextually-related data is received. For example, data representing a current position of the mobile device, such as Bluetooth low energy beacon signals, WiFi signals, and the like, may be monitored. In response to determining that the current position is within a threshold proximity of a first location, the user interface may be updated to emphasize a first location interface corresponding to the first location over interfaces corresponding to other locations.Type: GrantFiled: August 7, 2019Date of Patent: February 7, 2023Assignee: Transform SR Brands LLCInventors: Parag Kumar Garg, Nicholas Frank LaVassar, Joseph Reid Baird, Donald Smyth, Jonathan Kevin Gagliardoni, Darrin Michael Johnson
-
Patent number: 11151850Abstract: Techniques for providing status information of a defined location are described. Data indicative of signal strength associated with radio frequency (RF) signals received by one or more devices communicating via a wireless communications protocol is accessed. A baseline signal strength profile based on the data is determined. The data indicative of signal strength associated with RF signals received by the one or more devices is monitored. Based on a comparison of the monitored data to the baseline signal strength profile, a presence of at least one person in a vicinity of the one or more devices is determined. At least one action based on the determined presence is initiated.Type: GrantFiled: February 11, 2020Date of Patent: October 19, 2021Assignee: Transform SR Brands LLCInventors: Parag Kumar Garg, Nicholas Frank LaVassar, Joseph Reid Baird, Donald Smyth, Jonathan Kevin Gagliardoni, Daniel Sihe Kuang Lee
-
Publication number: 20200175831Abstract: Techniques for providing status information of a defined location are described. Data indicative of signal strength associated with radio frequency (RF) signals received by one or more devices communicating via a wireless communications protocol is accessed. A baseline signal strength profile based on the data is determined. The data indicative of signal strength associated with RF signals received by the one or more devices is monitored. Based on a comparison of the monitored data to the baseline signal strength profile, a presence of at least one person in a vicinity of the one or more devices is determined. At least one action based on the determined presence is initiated.Type: ApplicationFiled: February 11, 2020Publication date: June 4, 2020Inventors: Parag Kumar Garg, Nicholas Frank LaVassar, Joseph Reid Baird, Donald Smyth, Jonathan Kevin Gagliardoni, Daniel Sihe Kuang Lee
-
Patent number: 10621840Abstract: Techniques for providing status information of a defined location are described. Data indicative of signal strength associated with radio frequency (RF) signals received by one or more devices communicating via a wireless communications protocol is accessed. A baseline signal strength profile based on the data is determined. The data indicative of signal strength associated with RF signals received by the one or more devices is monitored. Based on a comparison of the monitored data to the baseline signal strength profile, a presence of at least one person in a vicinity of the one or more devices is determined. At least one action based on the determined presence is initiated.Type: GrantFiled: July 31, 2017Date of Patent: April 14, 2020Assignee: Transform SR Brands LLCInventors: Parag Kumar Garg, Nicholas Frank LaVassar, Joseph Reid Baird, Donald Smyth, Jonathan Kevin Gagliardoni, Daniel Sihe Kuang Lee
-
Publication number: 20200076636Abstract: Systems and methods for providing contextual interaction with connected devices are described. A mobile device having a display that presents a user interface enabling access to functionalities provided by connected devices. The user interface may be updated as various contextually-related data is received. For example, data representing a current position of the mobile device, such as Bluetooth low energy beacon signals, WiFi signals, and the like, may be monitored. In response to determining that the current position is within a threshold proximity of a first location, the user interface may be updated to emphasize a first location interface corresponding to the first location over interfaces corresponding to other locations.Type: ApplicationFiled: August 7, 2019Publication date: March 5, 2020Inventors: Parag Kumar Garg, Nicholas Frank LaVassar, Joseph Reid Baird, Donald Smyth, Jonathan Kevin Gagliardoni, Darrin Michael Johnson
-
Patent number: 10287299Abstract: A series of substituted 3,4-dihydro-2H-.1,4-benzoxazin-3-one derivatives, and analogs thereof, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neuradegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.Type: GrantFiled: June 7, 2016Date of Patent: May 14, 2019Assignee: UCB Biopharma SPRLInventors: Gareth Neil Brace, Prafulkumar Tulshibhai Chovatia, Gregory Foulkes, James Andrew Johnson, Severine Danielle Jones, Boris Kroeplien, Fabien Claude Lecomte, Pui Leng Loke, Martin Alexander Lowe, Ajay Mandal, Timothy John Norman, Christopher Francis Palmer, Yolanda Pérez-Fuertes, John Robert Porter, Donald Smyth, Giancarlo Trani, Muhammed Uddin, Zhaoning Zhu
-
Publication number: 20190035244Abstract: Techniques for providing status information of a defined location are described. Data indicative of signal strength associated with radio frequency (RF) signals received by one or more devices communicating via a wireless communications protocol is accessed. A baseline signal strength profile based on the data is determined. The data indicative of signal strength associated with RF signals received by the one or more devices is monitored. Based on a comparison of the monitored data to the baseline signal strength profile, a presence of at least one person in a vicinity of the one or more devices is determined. At least one action based on the determined presence is initiated.Type: ApplicationFiled: July 31, 2017Publication date: January 31, 2019Inventors: Parag Kumar Garg, Nicholas Frank LaVassar, Joseph Reid Baird, Donald Smyth, Jonathan Kevin Gagliardoni, Daniel Sihe Kuang Lee
-
Publication number: 20180212791Abstract: Systems and methods for providing contextual interaction with connected devices are described. A mobile device having a display that presents a user interface enabling access to functionalities provided by connected devices. The user interface may be updated as various contextually-related data is received. For example, data representing a current position of the mobile device, such as Bluetooth low energy beacon signals, WiFi signals, and the like, may be monitored. In response to determining that the current position is within a threshold proximity of a first location, the user interface may be updated to emphasize a first location interface corresponding to the first location over interfaces corresponding to other locations.Type: ApplicationFiled: June 6, 2017Publication date: July 26, 2018Inventors: Parag Kumar Garg, Nicholas Frank LaVassar, Joseph Reid Baird, Donald Smyth, Jonathan Kevin Gagliardoni, Darrin Michael Johnson
-
Publication number: 20180134728Abstract: A series of substituted 3,4-di-hydro-2H-.1,4-benzoxazin-3-one derivatives, and analogues thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.Type: ApplicationFiled: June 7, 2016Publication date: May 17, 2018Inventors: Gareth Neil Brace, Prafulkumar Tulshibhai Chovatia, Gregory Foulkes, James Andrew Johnson, Severine Danielle Jones, Boris Kroeplien, Fabien Claude Lecomte, Pui Leng Loke, Martin Alexander Lowe, Ajay Mandal, Timothy John Norman, Christopher Francis Palmer, Yolanda Pérez-Fuertes, John Robert Porter, Donald Smyth, Giancarlo Trani, Muhammed Uddin, Zhaoning Zhu
-
Patent number: 8278442Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity.Type: GrantFiled: May 22, 2008Date of Patent: October 2, 2012Assignee: Prosidion LimitedInventors: Jason Bloxham, Stuart Edward Bradley, Tom Banksia Dupree, Peter Timothy Fry, Patrick Eric Hanrahan, Thomas Martin Krulle, Martin James Procter, Colin Peter Sambrook-Smith, Karen Lesley Schofield, Donald Smyth, Alan John Stewart
-
Publication number: 20120077793Abstract: The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.Type: ApplicationFiled: March 12, 2010Publication date: March 29, 2012Applicant: PROSIDION LIMITEDInventors: Oscar Barba, Peter Timothy Fry, Matthew Colin Thor Fyfe, William Gattrell, Revathy Perpetua Jeevaratnam, Thomas Martin Krulle, Martin James Procter, Colin Peter Sambrook-Smith, Karen Lesley Schofield, Donald Smyth, Alan John William Stewart, David French Stonehouse, Simon Andrew Swain
-
Publication number: 20120059014Abstract: The present invention is directed to therapeutic compounds of the following formula (I) which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.Type: ApplicationFiled: March 12, 2010Publication date: March 8, 2012Applicant: PROSIDION LIMITEDInventors: Oscar Barba, Tom Banksia Dupree, Peter Timothy Fry, Matthew Colin Thor Fyfe, Revathy Perpetua Jeevaratnam, Thomas Martin Krulle, Karen Lesley Schofield, Donald Smyth, Thomas Staroske, Alan John William Stewart, David French Stonehouse, Simon Andrew Swain, David Matthew Withall
-
Patent number: 8063247Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful inter alia for the treatment of obesity.Type: GrantFiled: September 8, 2008Date of Patent: November 22, 2011Assignee: Prosidion LimitedInventors: Jason Bloxham, Stuart Edward Bradley, Thomas Martin Krulle, Martin James Procter, Colin Peter Sambrook-Smith, Karen Lesley Schofield, Donald Smyth
-
Publication number: 20100286112Abstract: The present invention is directed to therapeutic compounds which have dual activity as agonists of GPR119 and inhibitors of DPP-IV and are useful for the treatment of metabolic disorders including type II diabetes.Type: ApplicationFiled: September 10, 2008Publication date: November 11, 2010Inventors: Oscar Barba, Stuart Edward Bradley, Matthew Colin Thor Fyfe, Patrick Eric Hanrahan, Thomas Martin Krulle, Martin James Procter, Christine Reynet McCormack, Karen Lesley Schofield, Donald Smyth, Alan John William Stewart, Simon Andrew Swain, Peter Widdowson
-
Publication number: 20100267780Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful inter alia for the treatment of obesity.Type: ApplicationFiled: September 8, 2008Publication date: October 21, 2010Inventors: Jason Bloxham, Stuart Edward Bradley, Thomas Martin Krulle, Colin Peter Sambrook-Smith, Karen Lesley Schofield, Donald Smyth
-
Publication number: 20100173886Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity.Type: ApplicationFiled: May 22, 2008Publication date: July 8, 2010Inventors: Jason Bloxham, Stuart Edward Bradley, Tom Banksia Dupree, Peter Timothy Fry, Patrick Eric Hanrahan, Thomas Martin Krulle, Martin James Procter, Colin Peter Sambrook-Smith, Karen Lesley Schofield, Donald Smyth, Alan John Stewart
-
Publication number: 20090221645Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof, exhibit 5-HT1A agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition are useful for the treatment of obesity.Type: ApplicationFiled: February 8, 2006Publication date: September 3, 2009Inventors: Oscar Barba, Graham John Dawson, Thomas Martin Krulle, Robert John Rowley, Donald Smyth, Gerard Hugh Thomas